In 2022, a breast cancer patient filed a writ petition before the Kerala High Court, stating that one of the drugs prescribed for her condition, Ribociclib, was "too expensive and unavailable at an affordable price" because it was patented.
In 2022, a breast cancer patient filed a writ petition before the Kerala High Court, stating that one of the drugs prescribed for her condition, Ribociclib, was "too expensive and unavailable at an affordable price" because it was patented.
<iframe src="https://hindustansphere.com/embed/cluster/27adaf1fb903d787c1b98dccd87f43041d1016a7" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="57 Hearings And An Unanswered Call For Affordable Drugs: Court Seeks Reply"></iframe>
In 2022, a breast cancer patient filed a writ petition before the Kerala High Court, stating that one of the drugs prescribed for her condition, Ribociclib, was "too expensive and unavailable at an affordable price" because it was patented.
